Novartis reported net income of $7.8 billion in the second quarter of 2018 compared with $2 billion in the same quarter of 2017, according to a press release.
The increase in net income was attributed to the company’s sale of its stake in the GSK consumer health care joint venture.
Operating income increased from $2.3 billion to $2.5 billion.
Net sales increased 7% to $13.2 billion in the quarter compared with $12.2 billion in the same quarter a year ago.
Alcon, the company’s eye care business, which will be spun (Read more...)